Measuring serum total cholesterol: do vascular surgeons know what they are doing?

Area of Science:

• Cardiovascular Medicine
• Vascular Surgery
• Clinical Practice

Background:

• Elevated serum total cholesterol (TC) is a recognized risk factor for coronary and peripheral vascular diseases.
• Statins have demonstrated efficacy in lowering TC and reducing cardiovascular events.
• Current practices and beliefs among vascular surgeons regarding hypercholesterolemia management are not well-understood.

Purpose of the Study:

• To investigate the measurement and management of raised TC by vascular surgeons in Great Britain and Ireland.
• To assess vascular surgeons' beliefs about the benefits of lowering TC for cardiovascular outcomes and claudication.

Main Methods:

• A questionnaire was distributed to members of the Vascular Surgical Society of Great Britain and Ireland.
• The survey addressed TC measurement, normal levels, and thresholds for intervention.
• Surgeons' opinions on the impact of TC lowering on coronary mortality and claudication were solicited.

Main Results:

• A 67% response rate was achieved from 374 distributed questionnaires.
• Over 90% of respondents routinely measured TC, with 5.5 mmol/l commonly considered normal.
• Significant variation existed in the TC levels triggering drug therapy or specialist referral (5.5–7.5 mmol/l).
• While 62% believed lowering TC improved coronary mortality, only 26% felt it prevented claudication worsening.
• Nearly one-fifth of surgeons doubted the benefit of TC lowering for coronary mortality.

Conclusions:

• Most vascular surgeons measure TC, but treatment thresholds and approaches are inconsistent and often deviate from guidelines.
• There is limited surgeon confidence in the benefits of TC reduction for peripheral artery disease symptoms like claudication.
• Further education and guideline dissemination may be necessary to align surgical practice with evidence-based hypercholesterolemia management.